Research & Development

色姐姐色姐妹色姐妹综合第二届进博会倒计时100天 让国内外市场距离更近


  雲瑯歪著腮幫子用食指拇指捏著下巴上的火癤子,吸了一口涼氣狠狠地一捏……   敢指責木匠的人只能是出錢的人,如果每一個人都說,那麼只能說明,每一個人都是出錢的人。色姐姐   雲瑯說完,就背著手揚長而去。色姐妹   說實話,雲瑯這個家主現在多少有些無所事事的感覺。   狗子笑道︰“對我而言足夠了。”色姐妹综合   桑弘羊嘴上說的輕飄飄的,眼中的鄙夷之意卻快要從眼中流淌出來了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo